In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Can Merck Serono Bounce Back?

Executive Summary

Merck KGAA’s $13 billion acquisition of Serono in 2006 created an unwieldy pharmaceutical organization further hobbled by expensive clinical setbacks. Seven years later, driven by new leadership, it is in the midst of an overdue transformation.

Advertisement

Related Content

Rossetti Sets A High Bar At Merck Serono
Deal Watch: Merck KGAA Boosts Pharma Unit’s Reach And Capabilities With Sigma-Aldrich Buy
Merck KGaA Buys Sigma-Aldrich To Boost Lab Business, Expand Footprint
The Art Of Cutting Costs Without Jeopardizing Growth: An Interview With Merck Serono's Belén Garijo
Threshold Presses On In Two Phase III Cancer Trials As Competitors Wilt
EU’s IMI, Drug Makers And Universities Join In New R&D Effort
Prexton Therapeutics’ Parkinson’s Assets First to Emerge from Merck KGAA Restructuring
MS Boon: Many Drugs On The Way, But Will Payors Swallow The Cost?
Diversification Fails To Protect Merck KGaA From Industry Pressures
European Consolidation: Serious Competition for Big Pharma?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004069

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel